Monday, September 21, 2020 1:15:07 PM
But briefly.
We have just given half the US market to NeuroRx ..who were previously contract players for us ...contracted to run the US trials that we were paying for. . So thats a huge give and shows you how bad we need them to try and get this thru FDA approval. .
We don't know how well RLF-100 really works , who it works best on ...and how early to start putting patients on IV RLF-100...UNTIL we have the data from the properly powered double blinded placebo controlled trial we are currently running .
So we dont know if its really 90% effective based on the data we have so far ....the patient numbers are just too small to extrapolate that out to thousands of hospitalized Covid patients.
We need a time line for final enrollment of the IV trial.
Kiwi
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM